“APOL1 Plus” Genotypes in Patients with Chronic Kidney Disease | ASN Abstract

Emerging Research with Global Implications: Identification & Diagnosis of Kidney Diseases - APOL1Подробнее

Advances in APOL1 TherapeuticsПодробнее

APOL1 & Kidney Disease: Progress Toward Precision Medicine | DoM Grand Rounds | 30 March 2022Подробнее

Utility of Genetic Testing in Informing Management of Patients with Kidney Disease | ASN AbstractПодробнее

APOL1-Associated Nephropathy: Pathology, Mechanisms, and Clinical Utility - Dr. Barry FreedmanПодробнее

APOL1 Gene and African-American Susceptibility to Chronic Kidney Disease by John Sedor, MDПодробнее

APOL1 risk genotype in FSGS and other nephropathies - ERKNet Webinar with Aude ServaisПодробнее

NMQF Webinar: Understanding Genetic Kidney Diseases: Insights into APOL1Подробнее

Opinions of African American adults about APOL1 genetic testing in living donors | Journal clubПодробнее

Nephrology Update: Highlights from ASN Kidney Week 2023Подробнее

Update on APOL-1 NephropathiesПодробнее

APOL1-Mediated Kidney Disease Spotlight | American Kidney FundПодробнее

Understanding Genetic Kidney Diseases Insights: Insights into APOL1Подробнее

Living with APOL1-mediated kidney disease: Dr. Kendra Richardson’s story | Vertex PharmaceuticalsПодробнее

Webinar | APOL1-mediated kidney disease: Overview and Implications for Care | AKFПодробнее

APOL1-mediated kidney disease | Rare Kidney Disease | AKFПодробнее

Adriana Hung, MD, MPH - APOL1 Mediated Kidney Disease: Toward Precision Medicine ApproachesПодробнее

J. Ashley Jefferson, MD - APOL1 Mediated Kidney DiseaseПодробнее

Daniel Watford, MD, MPH - APOL1 Kidney Risk Variants and the APOLLO StudyПодробнее